Teleflex Incorporated $TFX Stock Position Cut by Invenomic Capital Management LP

Invenomic Capital Management LP cut its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 10.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 346,559 shares of the medical technology company’s stock after selling 39,113 shares during the quarter. Teleflex makes up approximately 2.0% of Invenomic Capital Management LP’s holdings, making the stock its 10th largest holding. Invenomic Capital Management LP owned about 0.78% of Teleflex worth $42,294,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Banque Cantonale Vaudoise increased its holdings in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares during the last quarter. V Square Quantitative Management LLC purchased a new stake in Teleflex during the 4th quarter worth approximately $37,000. UMB Bank n.a. increased its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares during the last quarter. Sound Income Strategies LLC purchased a new stake in Teleflex during the 4th quarter worth approximately $45,000. Finally, Kestra Advisory Services LLC purchased a new stake in Teleflex during the 4th quarter worth approximately $45,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a research report on Monday, April 13th. Truist Financial reiterated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and increased their price target for the company from $140.00 to $160.00 in a research report on Monday, June 8th. Finally, Needham & Company LLC increased their price target on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $146.00.

Teleflex Stock Down 2.2%

NYSE:TFX opened at $125.08 on Thursday. The firm has a market capitalization of $5.54 billion, a price-to-earnings ratio of -5.49, a PEG ratio of 0.95 and a beta of 0.82. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The business’s fifty day moving average price is $129.31 and its 200 day moving average price is $119.24.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.Teleflex’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, sell-side analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s payout ratio is presently -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.